COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Wisconsin, Madison

About this trial

The goal of this research study is to compare two ultrawide field cameras to the gold standard imaging system to evaluate the back of the eye. The main question it aims to answer is the same results and information can be acquired from all of the cameras for evaluating and monitoring inherited retinal diseases (IRDs).

Participants will:

* undergo pupillary dilation * have photographs taken of the inside of the eyes using three different cameras

Eligibility criteria

Qualifiers

Participants 18 years and older with a clinical and/ or genetic diagnosis of IRD recruited either from the clinic and/or the Inherited Ocular Disease Registry to participate in this trial

Participants that are willing to participate as evidenced by signing the written informed consent

Disqualifiers

Presence of ocular conditions other than an IRD which may affect the quality of ocular imaging including but not limited to advanced cataracts, corneal disorders, nystagmus, vitreous hemorrhage, or poor dilation

Presence of ocular conditions other than an IRD which may affect interpretation of retinal imagining including but not limited to epiretinal membrane, choroidal neovascular membrane, or macular scarring

Patients with advanced IRDs who are unable to fixate for imaging

Patients unable to tolerate ocular imaging

Trial design

Treatments tested in this trial

  • Spectralis FAF imaging
  • Optos imaging
  • Clarus imaging

Treatment groups

50 Participants
are divided into 1 treatment group